Le Moigne, R., et. al. Pre-clinical profile of EPI-7386, a second-generation N-terminal domain androgen receptor inhibitor for the treatment of prostate cancer. ESMO Virtual Congress 2020. (Poster ID #11P).

Read More > ESMO Virtual Congress 2020 Poster